[HTML][HTML] Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform …

…, LB Ribeiro, R Oliveira, O Harari, JI Forrest… - The Lancet Global …, 2022 - thelancet.com
Background Recent evidence indicates a potential therapeutic role of fluvoxamine for
COVID-19. In the TOGETHER trial for acutely symptomatic patients with COVID-19, we aimed to …

[HTML][HTML] Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada

W Zhang, N O'Brien, JI Forrest, KA Salters… - PloS one, 2012 - journals.plos.org
Objective To establish the reliability and validity of a shortened (10-item) depression scale
used among HIV-positive patients enrolled in the Drug Treatment Program in British Columbia…

[HTML][HTML] Effect of early treatment with ivermectin among patients with Covid-19

…, R Oliveira, O Harari, JI Forrest… - … England Journal of …, 2022 - Mass Medical Soc
Background The efficacy of ivermectin in preventing hospitalization or extended observation
in an emergency setting among outpatients with acutely symptomatic coronavirus disease …

[HTML][HTML] A real-time dashboard of clinical trials for COVID-19

K Thorlund, L Dron, J Park, G Hsu, JI Forrest… - The Lancet Digital …, 2020 - thelancet.com
In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial
research assessing the efficacy and safety of clinical candidate interventions to treat COVID-19 …

[HTML][HTML] Early treatment with pegylated interferon lambda for Covid-19

…, O Harari, LA Wilson, JI Forrest… - … England Journal of …, 2023 - Mass Medical Soc
Background The efficacy of a single dose of pegylated interferon lambda in preventing clinical
events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is …

Effect of early treatment with hydroxychloroquine or lopinavir and ritonavir on risk of hospitalization among patients with COVID-19: the TOGETHER randomized …

…, L Thabane, G Singh, JJH Park, JI Forrest… - JAMA Network …, 2021 - jamanetwork.com
Importance Data on the efficacy of hydroxychloroquine or lopinavir-ritonavir for the treatment
of high-risk outpatients with COVID-19 in developing countries are needed. Objective To …

[HTML][HTML] Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis

…, JJH Park, K Chan, ME Socias, N Ford, JI Forrest… - The lancet HIV, 2017 - thelancet.com
Background High adherence to antiretroviral therapy is crucial to the success of HIV
treatment. We evaluated comparative effectiveness of adherence interventions with the aim of …

Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis

…, M Vitoria, M Doherty, ME Socias, N Ford, JI Forrest… - The lancet HIV, 2016 - thelancet.com
Background New antiretroviral therapy (ART) regimens for HIV could improve clinical
outcomes for patients. To inform global guidelines, we aimed to assess the comparative …

Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011

CM Puskas, JI Forrest, S Parashar, KA Salters… - Current HIV/AIDS …, 2011 - Springer
A literature review of original research articles on adherence to antiretroviral therapy (ART)
in developed countries, covering January 2000 to June 2011, was conducted to determine if …

[HTML][HTML] Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study

…, E Remera, S Kanters, K Chan, JI Forrest… - The Lancet Global …, 2015 - thelancet.com
Background Rwanda has achieved substantial progress in scaling up of antiretroviral
therapy. We aimed to assess the effect of increased access to antiretroviral therapy on life …